摘要
目的:探讨上海市儿童接种国产甲型H1N1流感病毒裂解疫苗不良反应发生情况。方法:对本市中小学生接种甲型H1N1流感病毒裂解疫苗后,发生不良反应并来我院就诊的192例儿童进行观察记录。结果:所观察的发生不良反应的儿童中,男∶女比例为1.23∶1,年龄6~15岁。192例儿童患者中,接种当天和接种后第1天发生不良反应的分别为72例(37.5%)和70例(36.5%)。临床症状含发热的儿童176例(91.7%),高热51例。以全身伴呼吸系统症状的儿童最多,为181人。在明确记录恢复时间的149例儿童中,以就诊后3 d内恢复的为主,为101例(67.8%)。结论:国产甲型H1N1流感病毒裂解疫苗接种儿童后未出现严重不良反应,安全性较高。
Objective:To discuss the safety and occurrence of adverse reaction(ADR) of influenza virus A(H1N1) split vaccine after it had been used in children and adolescents in Shanghai. Methods:192 subjects with ADRs who had their H1N1 vaccine inoculation in our hospital were reviewed and recorded and their recovering process,followed up. Results:Among the children and adolescents(aged 6-15 years) with ADRs,gender ratio(M/F) was 1.23:1.In the 192 subjects with clear record of ADR occurring time,72(37.5%) occurred exactly on the day of while 70(36.5%) occurred on the day after vaccination.Fever was the most common clinical symptom(176,91.7%) and sometimes it could even be hyperpyrexia(51).Fever and respiratory symptoms occupied the maximum proportion among all kinds of ADRs.In 149 children and adolescents with clear record of recovery time,the majority(101,67.8%) were cured in 3 days after their visiting hospital.Conclusion:No severe adverse effects were found after the inoculation of domestic produced influenza virus A(H1N1) split vaccine,and it had its high safety in Chinese children and adolescents.
出处
《药物流行病学杂志》
CAS
2012年第9期428-431,共4页
Chinese Journal of Pharmacoepidemiology